newsfilter
← Latest News
Business Wire·

Organon to Present New Research on Access and Value at ISPOR 2026

New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women's health and general medicines portfolio Organon (NYSE:OGN), a global healthcare company with